<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 1 )*
-------
TheraTech, Inc.
-----------------------------------------------------------------
(Name of Issuer)
Common Stock
-----------------------------------------------------------------
(Title of Class of Securities)
883383101
----------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement ___. (A fee
is not required only if the filing person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
Page 1 of 3 pages
<PAGE>
CUSIP NO. 883383101 Page 2 of 3 pages
---------
13G
________________________________________________________________________________
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Pfizer Inc.
13-5315170
________________________________________________________________________________
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP *
(a)_____
Not Applicable (b)_____
________________________________________________________________________________
3 SEC USE ONLY
________________________________________________________________________________
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
________________________________________________________________________________
5 SOLE VOTING POWER
NUMBER OF 900,000
SHARES _________________________________________________________________
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY Not Applicable
EACH
REPORTING _________________________________________________________________
PERSON 7 SOLE DISPOSITIVE POWER
WITH 900,000
_________________________________________________________________
8 SHARED DISPOSITIVE POWER
Not Applicable
________________________________________________________________________________
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
900,000
________________________________________________________________________________
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES * Not Applicable
________________________________________________________________________________
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
4.4
________________________________________________________________________________
12 TYPE OF REPORTING PERSON *
CO
________________________________________________________________________________
* SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
Page 3 of 3 pages
ITEM 1. ISSUER
(a) TheraTech, Inc.
(b) 417 Wakara Way
Salt Lake City, Utah 84108
ITEM 2. PERSON FILING
(a) Pfizer Inc.
(b) 235 East 42nd Street
New York, NY 10017
(c) Delaware
(d) See cover page
(e) See cover page
ITEM 3. THIS STATEMENT IS NOT FILED PURSUANT TO RULES 13d-1(b) OR 13d-2(b).
ITEM 4. NOT APPLICABLE
ITEM 5. IF THIS STATEMENT IS BEING FILED TO REPORT THE FACT THAT AS OF THE DATE
HEREOF THE REPORTING PERSON HAS CEASED TO BE THE BENEFICIAL OWNER OF
MORE THAN FIVE PERCENT OF THE CLASS OF SECURITIES, CHECK THE
FOLLOWING X.
---
ITEM 6. NOT APPLICABLE
ITEM 7. NOT APPLICABLE
ITEM 8. NOT APPLICABLE
ITEM 9. NOT APPLICABLE
ITEM 10. NOT APPLICABLE
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
February 13, 1997
-----------------
Date
/S/ Eileen R. Walton
--------------------
Signature
Eileen R. Walton, Assistant Secretary
-------------------------------------
Name/Title
